(Press-News.org) Survival rates of the world's most common cancer might soon be increased with a new vitamin E treatment which could significantly reduce tumour regrowth.
Queensland University of Technology (QUT) prostate cancer researchers are leading the fight against a disease which kills 3000 Australian men a year.
Dr Patrick Ling, whose research will be a centrepiece of the new $354 million Translational Research Institute (TRI) when it opens in Brisbane, is leading a team of researchers who have identified a particular constituent of vitamin E, known as tocotrienol (T3), which can inhibit the growth of prostate tumours.
Construction of TRI officially began today (October 19) at the Princess Alexandra Hospital. The world-class facility brings together some of Queensland's best medical researchers from four leading Australian research facilities to turn their work into accessible and potentially life-saving health treatments.
Dr Ling's research has been funded by Davos Life Science in Singapore, who recently awarded him a further $128,000 to undertake a one-year study of the long-term effectiveness of T3 to prevent the recurrence of treated prostate cancer tumours.
"Prostate cancer is the most common type of cancer in developed countries," Dr Ling said.
"It is responsible for more male deaths than any other cancer, except lung cancer."
Dr Ling said existing chemotherapy and hormonal therapy treatment of prostate cancer was insufficient because it failed to kill off the prostate cancer stem cells (CSCs) which were believed to be responsible for the regrowth of tumours.
However, the research team have discovered a particular form of T3, called gamma-tocotrienol (γ-T3), can successfully kill off the prostate cancer CSCs.
"Currently there is no effective treatment for metastatic prostate cancer, because it grows back after conventional therapies in more than 70 per cent of cases," he said.
"But with γ-T3, QUT researchers have found a better way to treat prostate cancer, which has the potential to inhibit recurrence of the disease."
Dr Ling said in animal trials, γ-T3 completely inhibited tumour formation in more than 70 per cent of the mice implanted with prostate cancer cells and fed the vitamin E constituent in water. In the remaining cases, tumour regrowth was considerably reduced, while tumours reformed in 100 per cent of the control group.
The findings were published recently in the International Journal of Cancer.
The next stage of Dr Ling's study has begun and will determine the long-term effectiveness of the γ-T3 treatment, with plans to progress to clinical trials in the future.
"Previous clinical trials using another vitamin E constituent to inhibit prostate cancer development were unsuccessful, but these trials did not use the vitamin E constituent γ-T3," he said.
"Other research has found γ-T3 is also effective in suppressing other types of cancer, including breast, colon, liver and gastric."
Dr Ling said while not all vitamin E preparations had the active constituent, natural vitamin E obtained from palm oil was rich in γ-T3.
Professor Ross Young, from QUT's Institute of Health and Biomedical Innovation (IHBI), said one of TRI's greatest strengths was to bring together leading researchers.
"Collaboration, which combines the expertise of researchers from different disciplines and institutions to achieve common goals, will lead to better solutions," Professor Young said.
QUT Vice-Chancellor Professor Peter Coaldrake said TRI would greatly benefit Queensland's and Australia's economy and ability to attract the world's best researchers to our shores.
"By having this world-class facility producing research of the highest quality, we will be increasing Queensland's international competitiveness in research," Professor Coaldrake said.
INFORMATION:
TRI is a collaboration of QUT, the University of Queensland, Princess Alexandra Hospital and the Mater Medical Research Institute, with funding from the Australian Government, Queensland Government, The Atlantic Philanthropies, QUT and UQ.
Dr Ling is based at IHBI and the Australian Prostate Cancer Research Centre - Queensland, a comprehensive research centre to investigate new ways to treat prostate cancer established by QUT and the Princess Alexandra Hospital with funding from the federal government.
His research is funded by world-leading tocotrienol manufacturer Davos Life Science. The Singapore-based company produces γ-T3 from sustainable palm plantations.
Vitamin E in front line of prostate cancer fight
2010-10-20
ELSE PRESS RELEASES FROM THIS DATE:
The world is not flat: Exploring cells and tissues in three dimensions
2010-10-20
The cells and tissues in our bodies grow, develop and interact in a highly complex, three-dimensional world. Likewise, the various microbial pathogens that invade our bodies and cause infectious disease interact with this complex 3-D tissue milieu. Yet the methods of culturing and studying human cells have traditionally been carried out in two dimensions on flat impermeable surfaces. While such 2-D culturing and modeling efforts have produced a steady stream of critical insight into cell behavior and the mechanisms of infection and disease, 2-D cell cultures have key limitations ...
Alcohol increases reaction time and errors during decision making
2010-10-20
There has been an abundance of research on the effects of alcohol on the brain, but many questions regarding how alcohol impairs the built-in control systems are still unknown. A new study released in the January 2011 issue of Alcoholism: Clinical & Experimental Research, which is currently available at Early View, explores that subject in detail and found that certain brain regions involved in error processing are affected more by alcohol than others.
According to Beth Anderson, a postdoctoral fellow at the Olin Neuropsychiatry Research Centre at Hartford Hospital in ...
Fetal alcohol exposure associated with a decrease in cognitive performance
2010-10-20
Exposure to alcohol as a fetus has been shown to cause difficulties in memory and information processing in children
New findings indicate that visual perception, control of attention and demand processing may be involved in fetal alcohol-related learning problems
This information could potentially be used to help children affected with such difficulties
It has been known for many years that drinking alcohol while pregnant can cause serious and irreversible damage to the fetus. However, new research exploring memory deficits in children diagnosed with fetal alcohol ...
Heavy alcohol use suggests a change in normal cognitive development in adolescents
2010-10-20
Adolescence and puberty is a period of significant development in the brain
New findings indicate that excessive alcohol use selectively damages the frontal lobe, which is responsible for the development of social skills and judgment
This indicates that severe alcohol abuse may damage brain function, and the normal course of neural development in adolescents
Alcohol, to an adolescent, is often seen as a rite of passage. Many teenagers view alcohol (as well as other drugs) as a gateway to adulthood, but are often blissfully unaware of the damage that it can cause ...
CYP2E1 gene found to be associated with alcohol response in the brain
2010-10-20
The gene CYP2E1, which is located on the terminal region of chromosome 10, plays a major role in the metabolic processing of alcohol
New findings show that this gene is linked with a low sensitivity to alcohol and increased risk for alcoholism
CYP2E1 could therefore be used as a predictor for those who are at risk for alcoholism
The research into how alcohol reacts with the brain is a complex one, and has been relentlessly studied for many years. But a new study has shown, through linkage and association analysis on various family groups, that a gene originally ...
New vision correction options for baby boomers
2010-10-20
CHICAGO— Results of clinical research on new presbyopia treatments now available in Europe–and possibly available soon in the United States–were reported in today's Scientific Program of the 2010 Joint Meeting of the American Academy of Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology (MEACO). The AAO-MEACO meeting is the world's largest, most comprehensive ophthalmic education conference and is in session October 16 through 19 at McCormick Place, Chicago.
Presbyopia is Inevitable, but Blurry Vision is Not
From age 40 onward our eyes' lenses gradually ...
Cataract surgery saves lives, dollars by reducing auto crashes
2010-10-20
CHICAGO—Cataract surgery not only improves vision and quality of life for older people, but is also apparently a way to reduce the number of car crashes. The research will be presented today's at the Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. Cataract surgery not only improves vision and quality of life for older people, but is also apparently a way to reduce the number of car crashes. The research will be presented today's at the Scientific Program of the 2010 American Academy ...
Photovoltaic medicine
2010-10-20
WASHINGTON, D.C., (Oct. 19, 2010) -- Micro-scaled photovoltaic devices may one day be used to deliver chemotherapeutic drugs directly to tumors, rendering chemotherapy less toxic to surrounding tissue.
"In the first step, we were able to prove the concept," says Tao Xu, Ph.D., an assistant professor at the University of Texas in El Paso. Xu and his colleagues will present their findings today at the AVS 57th International Symposium & Exhibition, which takes place this week at the Albuquerque Convention Center in New Mexico.
Currently, chemotherapeutic drugs are piped ...
Atomic-level manufacturing
2010-10-20
WASHINGTON, D.C., (Oct. 19, 2010) -- The long-held dream of creating atomically precise three-dimensional structures in a manufacturing environment is approaching reality, according to the top scientist at a company making tools aimed at that ambitious goal.
John Randall, Vice President of Zyvex Labs in Richardson, Tex., says his researchers have demonstrated a process that uses a scanning tunneling microscope tip to remove protective surface hydrogen atoms from silicon one at a time and then adds single atomic layers of silicon only to those meticulously cleared areas. ...
Nanotube thermopower
2010-10-20
WASHINGTON, D.C., (Oct. 19, 2010) -- When weighing options for energy storage, different factors can be important, such as energy density or power density, depending on the circumstances. Generally batteries -- which store energy by separating chemicals -- are better for delivering lots of energy, while capacitors -- which store energy by separating electrical charges -- are better for delivering lots of power (energy per time). It would be nice, of course, to have both.
Today at the AVS 57th International Symposium & Exhibition, which takes place this week at the Albuquerque ...